These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10864347)

  • 1. Treatment strategies for chronic hepatitis C virus infection.
    Kasahara A
    J Gastroenterol; 2000; 35(6):411-23. PubMed ID: 10864347
    [No Abstract]   [Full Text] [Related]  

  • 2. Initial experience with ribavirin plus glycyrrhizin in renal allograft recipients with chronic hepatitis C.
    Anand AC; Seth AK; Nagpal A; Varma PP; Gadela SR; Baliga KV; Dutta V; Chopra GS
    Indian J Gastroenterol; 2004; 23(6):226-7. PubMed ID: 15627669
    [No Abstract]   [Full Text] [Related]  

  • 3. 'Yes, now you are free from chronic HCV infection, but . . .'.
    Toyoda H; Kumada T
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):9-10. PubMed ID: 16706803
    [No Abstract]   [Full Text] [Related]  

  • 4. Current status of antiviral therapy for chronic hepatitis C.
    Lemon SM
    Adv Exp Med Biol; 1999; 458():29-37. PubMed ID: 10549377
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatocellular carcinoma after sustained response to interferon in non-cirrhotic hepatitis C: flaws in the cure, or a clue to the flaws?
    Farrell GC
    J Gastroenterol Hepatol; 1999 Sep; 14(9):833-7. PubMed ID: 10535462
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term outcome after interferon therapy in patients with chronic hepatitis C.
    Buti M; Esteban R
    Ann Hepatol; 2007; 6(4):267-9. PubMed ID: 18007558
    [No Abstract]   [Full Text] [Related]  

  • 7. Interferon therapy reduces the risk for hepatocellular carcinoma.
    Brown JL
    Gut; 2000 Nov; 47(5):610-1. PubMed ID: 11034573
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon.
    Veldt BJ; Hansen BE; Ikeda K; Verhey E; Suzuki H; Schalm SW
    Scand J Gastroenterol; 2006 Sep; 41(9):1087-94. PubMed ID: 16938723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: management of chronic hepatitis C in patients with contraindications to anti-viral therapy.
    Carreño V
    Aliment Pharmacol Ther; 2014 Jan; 39(2):148-62. PubMed ID: 24279580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic hepatitis C: what to do if the first treatment failed?].
    Asselah T
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B50-9. PubMed ID: 12180309
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].
    Nishiguchi S; Kubo S; Shiomi S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):600-4. PubMed ID: 15359868
    [No Abstract]   [Full Text] [Related]  

  • 12. Concomitant diffuse large B-cell lymphoma and hepatocellular carcinoma in chronic hepatitis C virus liver disease: a study of two cases.
    Lin A; Kadam JS; Bodenheimer HC; Leonard J; Joyce MA; Lake-Bakaar G
    J Med Virol; 2008 Aug; 80(8):1350-3. PubMed ID: 18551608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma recurrence after direct antiviral agent treatment: A European multicentre study.
    Kolly P; Waidmann O; Vermehren J; Moreno C; Vögeli I; Berg T; Semela D; Zeuzem S; Dufour JF
    J Hepatol; 2017 Oct; 67(4):876-878. PubMed ID: 28733219
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C and interferon: fewer cases of liver cancer.
    Prescrire Int; 2013 Jul; 22(140):191. PubMed ID: 23951600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic hepatitis C in HIV-HCV coinfected patients].
    Gervais A
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B121-32. PubMed ID: 12180279
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of response to treatment in chronic hepatitis C].
    Leroy V; Hilleret MN
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B23-31. PubMed ID: 12180294
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatitis C and alcohol].
    Perlemuter G
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B105-11. PubMed ID: 12180277
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatitis C and liver transplantation].
    Durand F
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B82-90. PubMed ID: 12180312
    [No Abstract]   [Full Text] [Related]  

  • 19. Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.
    Tarao K; Fujiyama S; Ohkawa S; Miyakawa K; Tamai S; Hirokawa S; Masaki T; Tanaka K
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):164-9. PubMed ID: 15668491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comment on: "Effect of sustained virologic response on the incidence of hepatocellular carcinoma in patients with HCV cirrhosis".
    Ji F; Cai Z; Deng H
    Braz J Infect Dis; 2011; 15(4):410. PubMed ID: 21861021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.